Skip to main content
. 2021 Apr 21;11:632094. doi: 10.3389/fonc.2021.632094

Figure 2.

Figure 2

Survival curves of all pediatric AML patients according to the combined WT1 mutations and positive FLT3/ITD status. Probability of EFS (A) and OS (B) for patients according to the combined WT1 mutations and positive FLT3/ITD status, respectively.